O
OPRX
Optimizerx Corp
8.43
+0.21+2.49%After Hours: 8.50 +0.08 +0.89%19:30 10/13 EDT
OPEN/PREV CLOSE8.25/8.22
TODAY RANGE8.25-8.59
VOL154.76K
MARKET CAP158.69M
52 WEEK RANGE4.540-22.25
AVG VOL (3M)199.88K
% TURNOVER0.79%
TURNOVER--
P/E (TTM)34.90
% RANGE4.01%
EPS(TTM)0.2414
P/E(FORWARD)37.72
P/B1.210
BVPS6.96
DIVIDEND--
P/S1.444
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP134.95M
SHARES OUTSTANDING18.84M
NEXT EARNINGS11/04-11/09
FREE FLOAT16.02M
LOT SIZE1
EX-DATE05/14/2018
News
Press Releases
Financial Reports
Profile
Dow Jones·09/29 15:55
OptimizeRx Price Target Raised to $11.00/Share From $10.00 by B. Riley Securities
Dow Jones·09/29 15:55
OptimizeRx Is Maintained at Buy by B. Riley Securities
Benzinga·09/29 15:42
B. Riley Securities Maintains Buy on OptimizeRx, Raises Price Target to $11
TipRanks·09/29 12:36
OptimizeRx price target raised to $11 from $10 at B. Riley
NASDAQ·09/23 13:14
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
TipRanks·09/22 12:35
OptimizeRx announces integration with OpenPath
Seeking Alpha·09/18 11:30
OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook
Dow Jones·09/02 11:30
*OptimizeRx Appoints Troy Sarich as Co Advisor
TipRanks·08/21 00:23
OptimizeRx Earnings Call Balances Setbacks and Recovery
TipRanks·08/17 08:54
OptimizeRx reports Q2 EPS 16c, consensus 11c
TipRanks·08/17 08:54
OptimizeRx backs FY26 revenue view $95M-$100M, consensus $97.41M
TipRanks·08/17 08:43
OptimizeRx names Andy D’Silva CFO, Heather Favazza chief accounting officer
TipRanks·08/17 08:06
OptimizeRx price target lowered to $12 from $14 at Stifel
Same Industry
Name/Symbol
Change%
Price